BNR
Burning Rock Biotech Ltd
NASDAQ: BNR · HEALTHCARE · DIAGNOSTICS & RESEARCH
$17.00
+4.68% today
Updated 2026-04-30
Market cap
$222.76M
P/E ratio
—
P/S ratio
0.41x
EPS (TTM)
$-0.75
Dividend yield
—
52W range
$2 – $42
Volume
0.0M
WallStSmart proprietary scores
31
out of 100
Grade: F
Strong Sell
Investment rating
3.3
Growth
D5.0
Quality
C+2.0
Profitability
F6.7
Valuation
B—/9
Piotroski F-Score
—
—
Altman Z-Score
—
—
Industry rank
—
View all highly rated stocks (75+) →200 stocks currently score above 75
Price targets
Analyst target
$4.03
-76.29%
12-Month target
—
—
Intrinsic (DCF)
$256.22
Margin of safety
+88.73%
Price chart
X-Ray snapshot
Strengths
+ Free cash flow $16.39M — positive
+ 88.73% below intrinsic value
Risks
- Thin margins at -10.30%
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $563.24M | $537.43M | $515.82M | $524.87M | $539.57M |
| Net income | $-971.23M | $-653.69M | $-346.63M | $-53.84M | $-15.17M |
| EPS | — | — | — | — | $-0.75 |
| Free cash flow | $-691.33M | $-518.84M | $-265.17M | $-98.24M | $16.39M |
| Profit margin | -172.44% | -121.63% | -67.20% | -10.26% | -10.30% |
Peer comparison
Smart narrative
Burning Rock Biotech Ltd trades at $17.00. Our Smart Value Score of 31/100 indicates the stock is weak. TTM revenue stands at $539.57M. with profit margins at -10.30%. Our DCF model estimates intrinsic value at $256.22.
Frequently asked questions
What is Burning Rock Biotech Ltd's stock price?
Burning Rock Biotech Ltd (BNR) trades at $17.00.
Is Burning Rock Biotech Ltd overvalued?
Smart Value Score 31/100 (Grade F, Strong Sell). DCF value $256.22.
What is the price target of Burning Rock Biotech Ltd (BNR)?
The analyst target price is $4.03, representing -76.3% downside from the current price of $17.00.
What is the intrinsic value of Burning Rock Biotech Ltd (BNR)?
Based on our DCF model, intrinsic value is $256.22, a +88.7% margin of safety versus $17.00.
What is Burning Rock Biotech Ltd's revenue?
TTM revenue is $539.57M.
Company info
SectorHEALTHCARE
IndustryDIAGNOSTICS & RESEARCH
CountryChina
ExchangeNASDAQ
CurrencyUSD
Quick metrics
P/S ratio0.41x
ROE-9.92%
Beta1.60
50D MA$21.38
200D MA$16.44
Shares out0.01B
Float0.04B
Short ratio—
Avg volume0.0M
Performance
1 week—
1 month—
3 months—
YTD—
1 year—
3 years—
5 years—